Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > Barbie with type 1 diabetes from Mattel and Breakthrough T1D
Barbie worked closely with Breakthrough T1D and the community to accurately represent the condition.
Seeing Barbie proudly and stylishly represent type 1 diabetes helps raise awareness and normalises the condition in everyday culture. She shows young people with T1D that they’re seen, supported and never alone.
Sign up to hear inspiring stories and the latest updates in T1D research.
Subscribe to:
We are the leading global type 1 diabetes (T1D) research and advocacy charity, we help make everyday life better while driving toward cures.
We do this by connecting the brightest minds and investing in the most promising research, campaigning for access, and supporting the T1D community.
Tomorrow, we’ll make this condition a thing of the past.
US-based company Vertex has published promising figures from their cell therapy trial, showing advancements in stem cell research.
Six months after islet-cell transplant, a T1D patient continues to produce insulin without immunosuppression.
Explore the highlights from a year of bold research progress – milestones that are bringing us closer to cures.
